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Abstract
Background and Aim: The eucapnic voluntary hyperventilation (EVH) testing is a di-
agnostic tool for diagnostics of exercise-induced bronchoconstriction; while the test-
ing has become more common among children, data on the test's feasibility among 
children remain limited. Our aim was to investigate EVH testing feasibility among 
children, diagnostic testing cut-off values, and which factors affect testing outcomes.
Methods: We recruited 134 patients aged 10–16 years with a history of exercise-
induced dyspnoea and 100 healthy control children to undergo 6-min EVH test-
ing. Testing feasibility was assessed by the children's ability to achieve ≥70% of 
the target minute ventilation of 30 times forced expiratory volume in 1 s (FEV1). 
Bronchoconstriction was assessed as a minimum of 8%, 10%, 12%, 15% or 20% fall in 
FEV1. Patient characteristics were correlated with EVH outcomes.
Results: Overall, 98% of the children reached ≥70%, 88% reached ≥80%, 79% reached 
≥90% and 62% reached ≥100% of target ventilation in EVH testing; of children with a 
history of exercise-induced dyspnoea, the decline percentages were as follows: 24% 
(≥8% fall), 17% (≥10% fall), 10% (≥12% fall), 6% (≥15% fall) and 5% (≥20% fall) in FEV1, 
compared to 11%, 4%, 3%, 1% and 0% among the healthy controls, respectively. 
Healthy controls and boys performed testing at higher ventilation rates (p < .05).
Conclusion: Eucapnic voluntary hyperventilation testing is feasible among children 
aged 10–16 years and has diagnostic value in evaluating exercise-induced dyspnoea 
among children. A minimum 10% fall in FEV1 is a good diagnostic cut-off value. 
Disease status appears to be important covariates.
K E Y W O R D S
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1  | INTRODUC TION
Exercise-induced dyspnoea is a subjective experience of breathing 
discomfort during exercise (Weatherald, Lougheed, Taille, & Garcia, 
2017) and affects around 14% of school-age children (Johansson 
et al., 2018). The two primary reasons for exercise-induced dys-
pnoea include exercise-induced bronchoconstriction (EIB) and 
dysfunctional breathing (Johansson et al., 2015; Cichalewski et al., 
2015; Depiazzi & Everald, 2016). Dysfunctional breathing can be de-
fined as alteration in the normal patterns of breathing (Depiazzi & 
Everard, 2016), and the typical manifestations of DFB are vocal cord 
dysfunction and hyperventilation. The prevalence of the former is 
5%–20% (Cichalewski et al., 2015; Johansson et al., 2015; Tilles, 
2015), and the latter is 6%–8% among school-age children (de Groot, 
2011; Johansson et al., 2015). The proper diagnosis is important be-
cause the treatments of these conditions are quite different.
The American Thoracic Society (ATS) has recommended that 
EIB should be diagnosed by establishing changes in lung function 
provoked by exercise (Parsons et al., 2013). The eucapnic voluntary 
hyperventilation (EVH) test is an alternative method to other indi-
rect or direct bronchial challenge tests such as exercise challenge 
or methacholine challenge test that has been described as a sensi-
tive technique for diagnosing EIB (Anderson, Argyros, Magnussen, & 
Holzer, 2001; Dickinson, McConell, & Whyte, 2011). The EVH test 
has traditionally been used for elite athletes (Anderson et al., 2001; 
Dickinson et al., 2011) and is widely regarded as the gold standard 
tool for assessing EIB among athletes (Hull, Ansley, Price, Dickinson, 
& Bonini, 2016). A minimum 10% fall in forced expiratory volume in 
1 s (FEV1) is generally considered significant (Hallstrand et al., 2018; 
Parsons et al., 2013). There is only one large scale study in ordinary 
adults (Brummel, Mastronarde, Rittinger, Philips, & Parsons, 2009), 
where 71% of adults reached minimum 70% of target minute ven-
tilation, meaning 60% of maximal minute ventilation. In total, 28% 
of the study patients with asthma-like symptoms had 10% fall of 
FEV1%. On the other hand, 44 of 224 (20%) non-symptomatic adult 
elite athletes had minimum 10% fall of FEV1 after EVH (Price et al., 
2016). According ERS specificity is higher with criterion of minimum 
fall of 15% FEV1 compared cut-off 10% (Hallstrand et al., 2018). EVH 
can also provoke vocal cord dysfunction (Christensen & Rasmussen, 
2013; Turmel, Gagnon, Bernier, & Boulet, 2015).
Although the EVH test is standardized, very few studies to date 
have examined such testing among children. Previous studies have 
shown that subjects generally tolerate EVH testing (Chateaubriand 
do Nascimento Silva Filho MJ, 2015; Kirkby et al., 2015), but only a 
minority of children can reach the target minute ventilation during 
testing (Chateaubriand do Nascimento Silva Filho et al., 2015; Van 
der Eycken et al., 2016).
EVH testing is becoming more common among children for the 
diagnostics of exercise-induced dyspnoea, but the data remains 
scarce. In this study, we thus aimed to explore the feasibility of EVH 
testing among children with exercise-induced dyspnoea. We hy-
pothesized that EVH testing would be feasible among children aged 
10–16 years and that the test could provoke bronchoconstriction 
among children who experience exercise-induced dyspnoea. We 
also wanted to determine whether a cut-off value of a 10% fall in 
FEV1 could be used among children, much as such a cut-off value 
is recommended for adults. Finally, we have investigated whether 
patient characteristics might influence testing outcomes.
2  | MATERIAL AND METHODS
2.1 | Recruitment
The study was conducted at the paediatrics departments of the uni-
versity hospitals of Turku and Kuopio, Finland. The inclusion criteria 
included a suspicion of pathological reasons for exercise-induced dysp-
noea, exercise-induced bronchoconstriction or dysfunctional breathing 
in patients between 10 and 16 years. The exclusion criteria were physi-
cal inactivity, severe comorbidity or chronic autoimmune disease. The 
100 healthy controls, from the same age range, were recruited through 
local sports clubs. Their inclusion criteria included engaging in sporting 
activity without symptoms of exercise-induced dyspnoea, active asthma 
or severe comorbidity. The Ethics Committee of the Hospital District of 
Southwest Finland approved the study, and written informed consent 
was provided by all the participants and their guardians.
2.2 | Background data
The Childhood Asthma Control Test was completed by the partic-
ipants and their guardians (Liu et al., 2007). In addition, a written 
questionnaire, completed by the guardian, was used to collect infor-
mation about the subjects' previous medical history including doc-
tor diagnosed asthma ever, current sporting activity, allergies, and 
acute and chronic respiratory symptoms, including cough, exercise-
induced dyspnoea, running nose, fever and throat symptoms.
2.3 | Testing prerequisites
Beta2-agonists were not administered for 12 hr before the tests. The 
baseline FEV1 had to be at least 70% of the age- and height-related 
reference values (Koillinen, Wanne, Niemi, & Laakkonen, 1998). If a 
patient had an acute respiratory infection, then the test was post-
poned for 2 weeks.
2.4 | Flow-volume spirometry
The test began with baseline spirometry in which FEV1 was the 
main outcome (Moore, 2012). The subjects then underwent EVH 
testing, as described below, and spirometry was repeated 1, 5 and 
10 min after the test. Finally, patients were given 0.4 mg of salbu-
tamol in the form of a dry powder at the Turku Centre (Buventol 
Easyhaler: Orion Pharma) and as a spray at the Kuopio Centre 
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(Ventoline Evohaler: Glaxo Wellcome Production) with a Babyhaler 
spacer device (Glaxo Wellcome Production), based on each cen-
tre's routine clinical practice. The spirometry test was repeated 
15 min after the administration of salbutamol. During bronchodil-
atation testing, an improvement of 12% or more in FEV1 compared 
to baseline was interpreted as significant (Pellegrino et al., 2005).
2.5 | Eucapnic voluntary hyperventilation test
The duration of the EVH test was 6 min (Anderson et al., 2001; 
Burman et al., 2018). The test equipment is shown in Figure 1. The 
test involves the patient inhaling gas that contains oxygen plus 74% 
nitrogen and 5.1% carbon dioxide. The target minute ventilation 
in the EVH test was defined as 30 times each patient's baseline 
FEV1, which was equivalent to 85% of minute ventilation volume 
(Hallstrand et al., 2018; Parsons et al., 2013). The mouthpiece used 
was MicroGard II Bacterial/Viral Filter kit (ref V-892380), Vyaire 
Medical Inc. The feasibility of the EVH test was assessed by the 
ability of participating children to achieve the minimum 70% tar-
get level of the minute ventilation volume (Hallstrand et al., 2018; 
Parsons et al., 2013). Minute ventilation was measured using the 
mouthpiece airflow sensor in real time (Burman et al., 2018). The 
software (WinCPRS, Absolute Aliens Oy) used in the EVH test 
equipment allowed us to show in real time the continuous 10-s 
sliding average of the minute ventilation on the monitor graphically 
with the specific target level-line that allowed the study subject to 
maintain the targeted minute ventilation. At the end of the test, 
all ventilation data were saved, and the average minute ventilation 
was calculated for the 6-min examination time.
2.6 | Definitions of exercise-induced asthma and 
dysfunctional breathing
Exercise-induced asthma was defined if study physician suspected 
asthma and if objective proof of bronchial hyperresponsiveness 
(either 10% fall of FEV1 in EVH or free running test if was made, or 
minimum 12% improvement of FEV1 in bronchodilatation test com-
pared baseline value or exhaled nitric oxide (FeNO) minimum 35 ppb 
if was made).
Dysfunctional breathing was defined if objective symptoms 
such as inspiratory stridor, hyperventilation or other abnormalities 
of breathing occurred without bronchoconstriction during the EVH 
test (Depiazzi & Everard, 2016).
2.7 | Outcomes
The primary aim of this study was to investigate the feasibility of 
EVH testing by assessing whether participants could achieve ≥70% 
of the target minute ventilation; additional target levels of ≥80%, 
≥90% and ≥100% were also analysed. The second aim was to evalu-
ate whether a guideline-based cut-off value of a 10% fall in FEV1 
(Hallstrand et al., 2018; Parsons et al., 2013) provoked by hyper-
ventilation could differentiate cases from controls; additional target 
levels of 8%, 12%, 15% and 20% fall in FEV1 were also analysed. 
The third aim was to determine whether common patient charac-
teristics, age, sex, current physician-diagnosed asthma, Childhood 
Asthma Test score (Liu et al., 2007), current atopic eczema, baseline 
FEV1, achieved minute ventilation level (70%–99% vs. ≥100% level) 
or response to bronchodilator correlated with the EVH outcomes.
2.8 | Statistical analysis
SPSS version 22 (IBM Corp.) was used for the statistical analysis. 
For continuous parametric and non-parametric data, Student's t test 
and the Mann–Whitney U test or Kruskal–Wallis tests were used, 
respectively. For categorical data, the chi-square test, Fisher's exact 
test (when counts were <5) and McNemar's test (related samples) 
were used. Logistic regression analysis was used to adjust for age 
and sex during analyses of target minute ventilation between groups. 
The statistical significance was established at p < .05.
F I G U R E  1   EVH test equipment
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3  | RESULTS
3.1 | Study population
We enrolled 234 children; of these, 134 were cases with a history 
of exercise-induced dyspnoea, and 100 were controls without any 
exercise-induced symptoms.
3.2 | Subject characteristics
The mean age of the 234 children was 13.7 years (standard devia-
tion [SD] 1.9 years), and the mean baseline FEV1 was 96% of the 
predicted normal level (Table 1). Girls achieved a greater per cent 
predicted FEV1 than boys: (98.7% [SD 11.0] vs. 94.0% [SD 11.6]; 
p = .002). Cases with a history of exercise-induced dyspnoea were 
more often girls than among the controls (57% vs. 29%; p < .001), 
had more atopic eczema (33% vs. 19%; p = .018), more often had 
physician-diagnosed asthma (33% vs. 5%; p < .001) and had lower 
Childhood Asthma Test scores than the healthy controls (mean 
21.1 vs. 26.2 points; p < .001) (Table 1). The controls participated 
in competitive sporting activities more than the patients (p < .001), 
possibly due to fact that they were recruited from sports groups. 
No other differences in characteristics were found between the 
subjects (Table 1).
3.3 | Ability to maintain target minute ventilation 
during eucapnic voluntary hyperventilation testing
Of all 234 children, the minimum 70% of target minute ventilation 
was achieved by 229 (98%), ≥80% by 207 (88%), ≥90% by 185 (79%) 
and ≥100% by 144 (62%) of subjects. The boys achieved a mini-
mum 80% of the target minute ventilation (120 [93%] vs. 87 [83%]; 
p = .015) and the minimum 90% of target minute ventilation (112 
[87%] vs. 73 [70%]; p = .001) better than girls. None of the other 
patient characteristics were associated with the target minute venti-
lation level the subjects achieved (data not shown).
No differences were observed among cases and controls who 
achieved a minimum 70% of the target (130 [97%] vs. 99 [99%]; uni-
variable p = .40; sex-adjusted p = .52) or minimum 80% of the target 
(114 [85%] vs. 93 [93%]; univariable p = .061; sex-adjusted p = .20); 
see Figure 2. Healthy children achieved a minimum 90% of the target 
(98 [73%] vs. 87 [87%]; p = .001; sex-adjusted p = .071) and 100% of 
the target (73 [55%] vs. 71 [71%]; univariable p = .001; sex-adjusted 
p = .017), which were generally more positive than the cases, but 
after adjusting for sex, the significance in which a minimum of 90% 
of the target was reached was lost (Figure 2). Interestingly, all 26 
children who experienced bronchoconstriction reached a minimum 
70% of the target minute ventilation.
3.4 | Fall in forced expiratory volume in 1 s testing 
after eucapnic voluntary hyperventilation testing
Overall, the mean fall in FEV1 among all children was −4.9% (SD 
5.7%). Bronchoconstriction, assessed as a minimum 8% fall in FEV1, 
occurred among 44 (19%) of all 234 children; other rates included 
a minimum 10% fall in FEV1 26 (11%), a minimum 12% fall in FEV1 
16 (6.8%), a minimum 15% fall in FEV1 9 (3.8%) and a minimum 
20% fall in FEV1 7 (3.0%). Age, sex and diagnosis of atopic eczema 
or asthma did not affect the fall in FEV1 after the EVH (data not 
shown).
A greater fall in FEV1 was observed among the cases than among 
the controls (mean −6.0% vs. −3.6%; p = .010); see Figure 3. Cases 
had more bronchoconstriction than controls among every cut-off 
value: minimum 8% fall in FEV1: (32 [24%] versus 11 [11%], univari-
able p = .012), minimum 10% fall in FEV1: (22 [17%]) versus 4 [4%], 
univariable p = .003), minimum 12% fall in FEV1 (13 [9.7%] versus 
3 [3.0%], univariable p = .043), minimum 15% fall in FEV1 (8 [5.9%] 
versus 1 [1.0%], p = .048) and minimum 20% fall in FEV1 (7 [5.2%] 
versus 0 [0%], univariable p = .021, Figure 3).
No differences were noted among children who reached 70%–
99% of the target minute ventilation or children who reached 100% 
of the target in the bronchoconstriction-related findings (Table 2). 
There was no correlation between reaching target minute venti-
lation volume and fall of FEV1 after EVH, (Spearman correlation, 
r = .061; p = .359).
3.5 | Cut-off values in clinical decision-making
When we used a cut-off value of an 8% fall in FEV1, 32 of 43 (74%) 
children were cases, while using a cut-off value of 10% fall in FEV1, 
22 of 26 (85%) children were considered cases. The proportions in 







Age (years) 13.8 (1.8) 13.7 (2.9) .68
Gender (boys) 58 (43%) 71 (71%) <.001
Previous asthma: doctor 
diagnosed
42 (33%) 5 (5.0%) <.001
Atopic eczema: doctor 
diagnosed
42 (31%) 19 (19%) .018
Current parental smoking 21 (16%) 14 (14%) .71
Regular current sports club 
activity
113 (84%) 100 (100%) <.001
FEV1, per cent predicted 95.4 (11.8) 97.0 (11.3) .27
Childhood asthma test 
score (points)
21.1 (3.4) 26.2 (1.6) <.001
Note: Bold means p < .05. Data represent the means and standard 
deviations or the number of children and the percentage. FEV1: forced 
expiratory volume in 1 s. Independent samples t test, chi-square test 
and Fisher's exact test were used for statistics.
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cut-off values of 12% (81%) or 15% (89%) of cases were similar com-
pared to the cut-off value of 10%.
If a cut-off value of 12% had been used instead of a 10% value, 
then there would be a 41% reduction in positive findings among the 
cases. A cut-off value of 15% had a 64% reduction in positive find-
ings among the cases, and a 20% cut-off had a 68% reduction in 
positive findings among the cases (Figure 3).
3.6 | Sensitivity and specificity in different cut-off 
values to identify exercise-induced asthma
Sensitivity and specificity in different cut-off values are shown in 
Table 3.
3.7 | Bronchodilatation testing
Among all 234 children, the mean improvement in bronchodilata-
tion testing was 2.6% (SD 4.5%). A minimum 12% improvement in 
FEV1 was observed among 7 of 234 (3.0%) children. None of the 
patient characteristics affected bronchodilator response. No differ-
ences were noted among cases and controls in mean improvement 
of bronchodilatation testing (respectively, 2.8% vs. 2.4%; univariable 
p = .062) or proportion with a minimum 12% improvement in FEV1 
during bronchodilatation testing (5 [3.7%] vs. 2 [2.0%]; univariable 
p = .70). The analysis of FEV1 change in bronchodilatation test for the 
lowest value of FEV1 after EVH showed that the cases had greater 
improvement after salbutamol than controls (9.8% versus 6.4%; uni-
variable p = .001). In addition, the cases had more often minimum 20% 
improvement in FEV1 from the lowest value of FEV1 after EVH (11 
[8.3%] vs. 2 [2.0%]; univariable p = .045). An assessment of bronchodi-
latation response minimum 20% improvement from the lowest value 
of FEV1 after EVH compared to 12% improvement in FEV1 from the 
baseline improved sensitivity to EIA from 12% to 26% (Table 3).
3.8 | Dysfunctional breathing
Of the 134 cases, 16 (12%) had objective symptoms, such as inspira-
tory stridor, hyperventilation or other breathing abnormalities, with-
out significant fall of FEV1 and a lack of bronchodilator response. 
None of the healthy controls experienced dysfunctional breathing 
during EVH testing (p < .001).
4  | DISCUSSION
Three main results arose from this study. First, most of the 10- 
to 16-year-old children successfully conducted the EVH testing 
F I G U R E  2   Reaching target minute 
ventilation volume in EVH testing. The 
black column presents the proportion 
of cases; the grey column presents the 
proportion of controls; *p < .05. Target 
minute ventilation volume defined as 30 
times forced expiratory volume in 1 s
F I G U R E  3   Proportion (%) of children 
having bronchoconstriction in different 
cut-off values after EVH testing. The black 
column presents the proportion of cases; 
the grey column presents the proportion 
of controls; *p < .05; **p < .01. FEV1: 
forced expiratory volume in 1 s
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without any side effects, and 70% of the target may be considered 
an acceptable ventilation rate. The real-time aid of graphical and 
visual feedback was useful in maintaining ventilation rates. Second, 
a cut-off 10% fall in FEV1 is useful for identifying those patients with 
exercise-induced bronchoconstriction, and bronchodilatation test-
ing rarely appeared to be positive after EVH testing when using a 
cut-off of 12% from the baseline. Third, EVH testing is useful in iden-
tifying cases with dysfunctional breathing.
Almost all children were able to complete the EVH test at the 
70% target level, regardless of any symptoms they may have expe-
rienced during the test. The subjects tolerated the EVH test well, 
and no additional side effects except some couching due to in-
creased mucus production were observed among the participants. 
Interestingly, at high (90%–100% of the target) ventilation rates 
healthy children had better performance than cases. In contrast, 
many previous studies have shown that only the minority (range 0%–
27%) of the 8- to 18-year-old children has been able to perform the 
test at the same 100% of target ventilation rate (Chateaubriand do 
Nascimento Silva Filho et al., 2015; Jara-Gutierrez et al., 2019; Van 
der Eycken et al., 2016). Like in our study, the proportion of children 
reaching minimum 70% of target minute ventilation has been 83%–
100% of 8- to 20-year-old children in previous studies (Albuquerque 
Rodrigues Filho et al., 2018; Chateaubriand do Nascimento Silva 
Filho et al., 2015; Jara-Gutierrez et al., 2019; Van der Eycken et al., 
2016). In addition, among the general adult population, 70% of the 
target was achieved at a much lower rate (71%) than in our study 
(Brummel et al., 2009). The graphical real-time biofeedback signal 
data, which enabled the children to regulate their ventilation effort-
lessly, might have played a role in the positive results. Another key 
success factor might have been the research personnel's encourage-
ment during the testing.
Children with previous asthma diagnosis had no more bronchoc-
onstriction than children without asthma diagnosis in early child-
hood. This could be because many children with clinical diagnosis of 
asthma in early childhood had actually suffered from virus-induced 
wheezing rather than “real asthma.”
In our study, a 10% cut-off in the fall in FEV1 after EVH testing 
was considered optimal for the diagnosis of bronchoconstriction, be-
cause it most strikingly differentiated cases from controls. Cut-offs of 
≥10 to ≥20% had specificity to identify exercise-induced asthma at 
98%–99%, but they also markedly decreased the sensitivity from 51% 
to 16%, implying that if the cut-off minimum 20% instead of 10% is 
used, the sensitivity would decrease significantly. Ventilation rate had 
no influence on this difference, which further supports the target min-
ute ventilation of ≥70% during EVH testing among 10- to 16-year-old 
children. Our results are in agreement with current recommendations, 
according to ATS and ERS (Hallstrand et al., 2018; Parsons et al., 2013).
Bronchodilatation changes were identical in both groups but if 
the changes were evaluated from the lowest value in FEV1, there 
were significant differences between the groups. Moreover, sensi-
tivity to identify EIA improved significantly. Results of our study are 
similar to a previous study done on swimmers (Romberg, Tufvesson, 
& Bjermer, 2012), and it may offer more relevant information com-
pared to calculating changes from the baseline.
Eucapnic voluntary hyperventilation testing is excellent for ob-
serving dysfunctional breathing, and in our study such breathing oc-
curred among 12% of cases and 0% of controls. This finding was in 
agreement with the prevalence of dysfunctional breathing, with a 
prevalence of 6% to 8% among the general and adolescent popula-
tion (Christensen, Thomsen, Rasmussen, & Backer, 2011; Johansson 
et al., 2018).
The males in our study were able to reach target minute ventila-
tion better than the females. A similar finding was also found in the 
largest study on EVH to have been conducted to date among the 
general population (Brummel et al., 2009. However, girls achieved a 
TA B L E  2   Test results among 229 subjects who reached a minimum 70% of target according to minute ventilation volume
Cut-off level
Children with 70%–99% of target MVV
(n = 87)
Children who reached 100% of target MVV
(n = 142) p-value
10% fall of FEV1 among cases 5/58 (8.6%) 14/72 (19%) .083
15% fall of FEV1 among cases 2/58 (3.5%) 6/72 (8.3%) .30
10% fall of FEV1 among controls 2/29 (6.9%) 2/70 (19%) .58
15% fall of FEV1 among controls 1/29 (3.5%) 0/70 (0.0%) .29
Note: Data represent the number of children and the percentage. FEV1: forced expiratory volume in 1 s; MVV: minute ventilation volume. Chi-square 
testing was used for statistics.
TA B L E  3   Sensitivity and specificity to exercise-induced asthma 





Fall of FEV1 ≥ 8% after EVH 56 90
Fall of FEV1 ≥ 10% after EVH 51 98
Fall of FEV1 ≥ 12% after EVH 30 98
Fall of FEV1 ≥ 15% after EVH 19 99
Fall of FEV1 ≥ 20% after EVH 16 100
Bronchodilatation improvement ≥ 12% 
of FEV1 compared baseline
12 99
Bronchodilatation improvement ≥ 15% 
of FEV1 compared lowest value
44 96
Bronchodilatation improvement ≥ 20% 
of FEV1 compared lowest value
26 99
Note: EVH: eucapnic voluntary hyperventilation test; FEV1: forced 
expiratory volume in 1 s.
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greater per cent predicted FEV1, which was probably the explana-
tion for the difference. Age, diagnosis of atopic eczema or asthma, 
baseline FEV1 or fall in FEV1 after EVH did not affect the results 
we obtained in our study. In a previous study, a fall in FEV1 did 
not affect the reaching of target minute ventilation (Chateaubriand 
do Nascimento Silva Filho et al., 2015). Previous studies' potential 
confounding factors have not usually been reported.
To our knowledge, this was the largest study using EVH testing 
to have been conducted with children, which is a major strength of 
the study. One limitation of the study is that spirometry follow-up 
after EVH was not made according ERS recommendations every 
3 min. First spirometry follow-up was made 1 min after EVH and 
fatigue might have affected first spirometry obtained. Another lim-
itation of our study was that both cases and control children were 
actively engaged in sports. Their target minute ventilation achieve-
ments during EVH testing may not have been as good if the controls 
had been physically inactive. Our results are thus generalizable only 
to those who are active in sports. The proportion of males among 
the controls was higher compared to the cases, but sex-adjusted 
analyses showed that the findings were independent of sex.
We found that EVH testing is feasible for 10- to 16-year-old chil-
dren. The reaching of a minimum 70% of target minute ventilation 
volume may be considered acceptable performance. Another finding 
was that a cut-off value of a minimum 10% fall in FEV1 also works 
well among children. EVH testing is also useful in identifying cases 
with dysfunctional breathing. Our data provide important evidence 
for the current ERS and ATS guidelines (Hallstrand et al., 2018; 
Parsons et al., 2013).
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